Trial Profile
CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Abacavir; Atazanavir; Efavirenz; Emtricitabine; Etravirine; Lamivudine; Lopinavir/ritonavir; Maraviroc; Ritonavir; Tenofovir disoproxil fumarate; Zidovudine
- Indications HIV infections
- Focus Pharmacokinetics
- 01 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2012 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 19 Jul 2011 Planned end date changed from 1 May 2011 to 1 Jan 2013 as reported by ClinicalTrials.gov record.